Evommune EVMN
NYSE EVMN
$6.88 -0.31 (-4.31%)
At close: Oct 2, 2026 · 4:00 PM EDT

Evommune (EVMN) Price to Sales (2025 - 2026)

Updated

Evommune's (EVMN) Price to Sales came in at 48.22 for Q2 2026, down 41.8% from the prior quarter.

Analysis

Evommune (EVMN) Price to Sales (2025 - 2026) Analysis & Trends

For FY2025, Evommune's Price to Sales stood at 8.08.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Evommune 249.62 Mn -387.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.22
Mar 31, 2026 82.81
Dec 31, 2025 8.08
API Access

Evommune Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=EVMN&period=max&api_key=YOUR_API_KEY